Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Atomoxetine in Comorbid ADHD/PTSD: A Pilot, Placebo-Controlled Feasibility Study

NCT02287038 is registered in ClinicalTrials.gov with VA Office of Research and Development as lead sponsor.

NCT NCT02287038
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02287038 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Atomoxetine in Comorbid ADHD/PTSD: A Pilot, Placebo-Controlled Feasibility Study
Lead sponsor
VA Office of Research and Development
Phase
Phase 4
Overall status
Completed
Start date
October 15, 2014
Completion date
April 14, 2017
Enrollment
44 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

attention deficit hyperactivity disorder, post traumatic stress disorder